24 Month Open Label Study of the Tolerability and Efficacy of Inotersen in TTR Amyloid Cardiomyopathy Patients
Clinical trial NCT03702829 · TERMINATED
Trial details
- NCT number
- NCT03702829
- Sponsor
- Brigham and Women's Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-28
- Primary completion
- 2021-12-31
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.